PCSK9 inhibitors and methods of use thereof
Grant
US12584120B2
Kind: B2
Mar 24, 2026
Assignee
AstraZeneca AB
Inventors
Michael H. Serrano-Wu, Brian K. Hubbard, Virendar Kaushik, Doug Daniels
Abstract
The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein.
CPC Classifications
C12N 9/6424
C07D 413/12
C07D 403/12
Filing Date
2023-01-25
Application No.
18159270
Claims
20